APA (7th ed.) Citation

Yan, Q., Chen, Y., Tang, B., Xiao, Q., Qu, R., Tong, L., . . . Li, Y. (2018). Discovery of novel 2,4-diarylaminopyrimidine derivatives as potent and selective epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M resistance mutation. European Journal of Medicinal Chemistry, 152, 298. https://doi.org/10.1016/j.ejmech.2018.04.052

Chicago Style (17th ed.) Citation

Yan, Qi, et al. "Discovery of Novel 2,4-diarylaminopyrimidine Derivatives as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors Against L858R/T790M Resistance Mutation." European Journal of Medicinal Chemistry 152 (2018): 298. https://doi.org/10.1016/j.ejmech.2018.04.052.

MLA (9th ed.) Citation

Yan, Qi, et al. "Discovery of Novel 2,4-diarylaminopyrimidine Derivatives as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors Against L858R/T790M Resistance Mutation." European Journal of Medicinal Chemistry, vol. 152, 2018, p. 298, https://doi.org/10.1016/j.ejmech.2018.04.052.